Patent US9639150 message

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+) Patent US9639150 message

Filing Names

Novo Nordisk A s
Novo Nordisk A s Novo Alle
Novo Nordisk A s Novo All xe9
Novo Nordisk A s A Corporation
Novo Nordisk A s_20100107
Novo Nordisk A s_20100114
Novo Nordisk A s_20131212
Novo Nordisk A s_20100128
Novo Nordisk A s_20100121

Novo Nordisk A s patents

Recent patent applications related to Novo Nordisk A s. Novo Nordisk A s is listed as an Agent/Assignee. Note: Novo Nordisk A s may have other listings under different names/spellings. We're not affiliated with Novo Nordisk A s, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "N" | Novo Nordisk A s-related inventors

Date Novo Nordisk A s patents (updated weekly) - BOOKMARK this page
06/22/17 new patent  Nut assembly for a medical device
06/22/17 new patent  Telescopic drive arrangement with oldham coupling
06/15/17Process for the preparation of insulin-zinc complexes
06/15/17Automatic injection device with a top release mechanism
06/08/17Drug delivery device with indicator guidance
06/01/17Motorized drug delivery device
05/25/17Autoinjector having needle shield triggering
05/25/17Telescopic drive arrangement for drug delivery device
05/25/17Novel amylin and calcitonin receptor agonist
05/25/17Glp-1 derivatives
05/18/17Glycopegylated factor ix
05/18/17Pen-type drug injection device having multiple-use needle module with needle cleaning reservoir
05/18/17Injection device having needle shield locking
05/04/17A pen-shaped torsion spring driven injection device
04/27/17Double-acylated glp-1 compounds
04/27/17Antibodies against tissue factor pathway inhibitor
04/20/17A needle arrangement
04/13/17Glp-1/glucagon receptor co-agonists for medical use
04/06/17Dipeptide comprising a non-proteogenic amino acid
03/30/17Injection device having automatic needle retraction
03/23/17Drug delivery device with cap induced needle movement
03/16/17Selective elimination of erosive cells
03/16/17Therapeutic antibodies
03/09/17Factor viii variants having a decreased cellular uptake
03/02/17Double-acylated glp-1 derivatives
03/02/17Integrated continuous biomanufacturing process
02/23/17Novel glucagon analogues
02/16/17Treatment of diabetes type 1 using glp-1 and anti-il-21
02/16/17Methods for the purification of proteins using caprylic acid
01/26/17Factor viii molecules with reduced vwf binding
01/19/17Autoinjector having needle shield triggering
01/19/17Factor viii fusion protein
01/12/17Derivatives of glp-1 like peptides, and uses thereof
01/12/17Glycopegylation methods and proteins/peptides produced by the methods
01/12/17Telescopic drive arrangement
01/12/17A cartridge and needle assembly in combination
01/12/17Novel peptides and peptide derivatives and uses thereof
01/12/17Stable glucagon analogues and use for treatment of hypoglycaemia
01/12/17Novel insulin derivatives and the medical uses hereof
01/05/17A housing for a medical injection device
12/29/16Mating factor alpha pro-peptide variants
12/15/16Glycopegylated factor ix
12/15/16An injection apparatus
12/08/16Dose titration aid
12/08/16Dose titration aid
12/08/16Injection device with an end of dose feedback mechanism
12/08/16Stable, protracted glp-1/glucagon receptor co-agonists for medical use
12/01/16Novel glucagon analogues
12/01/16Antibody process
11/17/16Motorized drug delivery device with charging safety feature
11/10/16Transmission arrangement for motorized drug delivery device
11/10/16Shielding mechanism for an injection apparatus
11/10/16Generation of pancreatic endoderm from pluripotent stem cells using small molecules
11/03/16Auto-injection device with button activation
11/03/16Mechanical dose expelled indicator
11/03/16Compounds suitable for treatment of haemophilia
11/03/16Enterokinase cleavable polypeptides
10/13/16Dosing regimen
10/13/16Medical device and cartridge
10/13/16Novel methods and antibodies for treating coagulapathy
10/06/16Rotary sensor assembly with space efficient design
10/06/16Rotary sensor assembly with axial switch and redundancy feature
10/06/16Rotary sensor module with resynchronization feature
10/06/16Selective pyy compounds and uses thereof
09/22/16Acylated glucagon analogues
Patent Packs
09/22/16Injection device with a needle cannula
09/22/16Novel amylin and calcitonin receptor agonist
09/22/16Targeting tissue factor to activated platelets
09/15/16Coagulation factor-targeting to tlt-1 on activated platelets
09/15/16Drug delivery device with time indicator feature
09/15/16Stabilized factor viii variants
09/08/16Drug delivery device with front loading feature
09/01/16Targeted delivery of factor viii proteins to platelets
09/01/16Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
08/25/16Dose setting mechanism for an injection device and having a preset feature
08/18/16Drug delivery device with brake mechanism
08/11/16Drug delivery device with improved dose reset mechanism
08/11/16Novel insulin derivatives
08/04/16Injection device for selective fixed or variable dosing
08/04/16Conjugated factor viii molecules
Patent Packs
07/28/16Novel derivative of an insulin analogue
07/21/16Compounds suitable for treatment of haemophilia
07/21/16Generation of endocrine progenitor cells from human pluripotent stem cells using small molecules
07/14/16Glp-1 derivatives, and uses thereof
07/14/16Factor viii: remodeling and glycoconjugation of factor viii
07/07/16Pharmaceutical composition for oral insulin administration comprising a tablet core and an anionic copolymer coating
07/07/16Factor viii: remodeling and glycoconjugation of factor viii
06/30/16Glycopegylated factor ix
06/09/16Remodeling and glycopegylation of fibroblast growth factor (fgf)
06/09/16Anitbodies that bind urokinase plasminogen activator
06/02/16Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
06/02/16Antibodies recognizing the n-terminal part of tissue factor pathway inhibitor capable of eliciting pro-coagulant activity
05/26/16Glp-1 derivatives and uses thereof
05/19/16Novel uses of glp-1 receptor agonists in patients treated with insulin and/or suffering from type 1 diabetes
05/12/16Mic-1 fusion proteins and uses thereof
05/12/16Torsion spring injection device having an end-of-dose mechanism
05/12/16Drug delivery device with dual layer spring
05/05/16Factor viii conjugates
05/05/16Pharmaceutical composition suitable for treatment of haemophilia
05/05/16Fusion protease
04/28/16Frontloaded drug delivery device with actuated cartridge holder and piston rod coupling
04/28/16Method for making mature insulin polypeptides
04/21/16Novel oral pharmaceutical composition for treatment of diabetes
04/21/16Medical injection device
04/21/16Drug delivery device and system with pre-set dose feature
04/21/16Novel glp-1 derivatives
04/14/16Stable glp-1 based glp-1/glucagon receptor co-agonists
04/07/16Drug delivery device with piston rod coupling
04/07/16Methods for producing peptides using engineered inteins
03/31/16Drug delivery device with means for disabling activation of expelling mechanism
Social Network Patent Pack
03/31/16Frontloaded drug delivery device with dynamic axial stop feature
03/24/16Double-acylated glp-1 derivatives
03/24/16Novel peptidyl alpha-hydroxyglycine alpha-amidating lyases
03/17/16Fixation of a torsion spring
03/10/16Oral dosing of glp-1 compounds
03/03/16Novel administration regime
03/03/16Use of c5ar antagonists
02/25/16Dose logging device for a drug delivery device
02/25/16Drug delivery device with integrated magnetic movement indicator
02/18/16Drug delivery device and logging module assembly
Patent Packs
02/11/16Drug delivery device with compact power unit
02/11/16Human cd30 ligand antigen binding proteins
02/04/16Logging device adapted to combine doses
02/04/16Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitor
01/28/16Antibodies against human nkg2d and uses thereof
01/28/16Thrombin sensitive coagulation factor x molecules
01/21/16Rotary sensor module with axial switch
01/21/16Mic-1 fusion proteins and uses thereof
01/14/16Dose capturing cartridge module for drug delivery device
01/07/16Liquid factor viii formulations
01/07/16Injection needle having shield activated valve
01/07/16Novel glucagon analogues
01/07/16Factor viii variants having a decreased cellular uptake
12/31/15Stable, protracted glp-1/glucagon receptor co-agonists for medical use
12/31/15Factor viii molecules with reduced vwf binding
12/24/15Drug delivery device with dose capturing module
12/24/15A non-axial working end-of content mechanism and an injection device comprising the same
12/24/15Novel glucagon analogues
12/17/15High temperature dead end antibody filtration
12/10/15Medical injection system with dose capturing
12/03/15Glycopegylation methods and proteins/peptides produced by the methods
12/03/15Drug delivery device with shield operated needle actuator
12/03/15State changing appliance for a drug delivery device
12/03/15Novel glp-1 receptor agonists with cholesterol efflux activity
11/26/15Drug delivery device with front loading feature
11/26/15A needle device
11/12/15Injection device with integrated needle shield
11/05/15Automatic injection device with a top release mechanism
10/22/15Drug delivery device with variable dose setting mechanism
10/22/15Dose setting mechanism for an injection device capable of presetting a maximum dose
Patent Packs
10/08/15Determination of a tendency to gain weight
10/01/15Fatty acid acylated amino acids for oral peptide delivery
10/01/15Pre-filled disposable injection device
10/01/15Medical assembly with monitoring device
10/01/15Acylated glucagon analogues
10/01/15Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (trem-1)
10/01/15Antibody toxin conjugates
09/24/15Fatty acid acylated d-amino acids for oral peptide delivery
09/24/15Spring driven injection device
09/24/15Determination of reduced gut bacterial diversity
09/17/15Glycerol linked pegylated sugars and glycopeptides
09/10/15Process for the preparation of insulin-zinc complexes
09/03/15Generation of pancreatic endoderm from pluripotent stem cells using small molecules
08/27/15Therapeutic factor viii antibodies
08/13/15Factor viii conjugates
08/13/15Coagulation factor ix conjugates
08/13/15Factor vii conjugates
07/30/15Double-acylated glp-1 derivatives with a linker
07/30/15Protease stabilized acylated insulin analogues
07/30/15Protease stabilized acylated insulin analogues
Social Network Patent Pack
07/23/15Spring driven injection device
07/23/15Spring-loaded injection device with an injection button
07/16/15Medical injection device
07/16/15Anti-kir antibodies, formulations, and uses thereof
07/16/15Piston rod foot
07/02/15Novel glucagon analogues
07/02/15Preparation comprising insulin, nicotinamide and an amino acid
06/25/15Shield lock for spring driven injection device
06/11/15Device for injecting apportioned doses of liquid drug
06/11/15Low friction systems and devices
06/04/15Tablet formulation comprising a peptide and a delivery agent
06/04/15Selective pyy compounds and uses thereof
06/04/15Double-acylated glp-1 derivatives
05/28/15Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids
05/28/15Dial-down mechanism for wind-up pen
05/21/15Pancreatic peptide compounds and use
05/14/15Double-acylated glp-1 derivatives
05/07/15Glycopegylated factor ix
05/07/15Pharmaceutical composition
05/07/15Insulin formulations
Social Network Patent Pack
04/23/15Glycopegylated follicle stimulating hormone
04/23/15Novel use of insulin derivatives
04/16/15Coagulation factor vii polypeptides
04/16/15Medical injection device comprising a secondary safety limiter
04/09/15Injection device
03/26/15Stabilised protein solutions
03/26/15Drug delivery device and detection of end-of-dose condition
03/19/15Drug delivery device with piston proximity sensing
03/19/15Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left
03/12/15Anti-nkg2a antibodies and uses thereof
03/12/15Compositions of glp-1 peptides and preparation thereof
03/05/15Modified enterokinase light chain
03/05/15Medical injection device
03/05/15Medical delivery device with regimen identification feature
02/12/15Therapeutic antibodies
02/12/15Glp-1 prodrugs
02/12/15Pharmaceutical composition suitable for treatment of haemophilia
02/05/15Glp-1 agonists
02/05/15N-terminally modified oligopeptides and uses thereof
02/05/15Safety needle assembly
02/05/15Injection device with a sliding scale
02/05/15Injection device
01/29/15Compositions comprising a delivery agent and preparation thereof
01/29/15End of dose indicator
01/29/15System and assisting in the home treatment of a medical condition
01/22/15Glucagon-like peptide-1 derivatives and their pharmaceutical use
01/22/15Revolving needle magazine
01/22/15Automatic injection device with reset feature
01/22/15Syringe device
01/15/15Antibodies that bind peptidoglycan recognition protein 1
Social Network Patent Pack
01/08/15Derivatives of glp-1 like peptides, and uses thereof
12/25/14Medical system configured to collect and transfer data
12/18/14Insulin derivatives containing additional disulfide bonds
12/18/14Adaptive system for optimizing a drug dosage regimen over time
12/11/14Dipeptide comprising a non-proteogenic amino acid
12/04/14N-terminally modified insulin derivatives
11/13/14Drug filled delivery assembly
11/06/14Magnetic time delay indicator and an injection device incorporating such
10/30/14Injection pen with mechanical dose display comprising large ciphers
10/09/14Glp-1 derivatives
10/09/14Injection device with torsion spring and rotatable display
10/02/14Glycopegylation methods and proteins/peptides produced by the methods
10/02/14Antagonistic dr3 ligands
10/02/14Truncated glp-1 derivatives and their therapeutical use
09/18/14Injection device comprising an optical sensor
09/18/14Arrangement for sequential delivery of fluid volumes
09/18/14Injection device for delivering a fixed dose of liquid drug
09/11/14Pharmaceutical compositions for oral administration of insulin peptides
09/11/14Medical injection system comprising a medical injection device and a dose limiter module
09/04/14Piston rod foot
08/28/14Conjugated factor viii molecules
08/28/14System for determining position of element
08/28/14Process for shaping a needle cannula
08/21/14Efficient induction of definitive endoderm from pluripotent stem cells
08/14/14Multi-substituted insulins
08/14/14Integrated package
08/07/14Combined use of a modulator of cd3 and a glp-1 compound
07/24/14Electrolytic cip-cleaning process for removing impurities from the inner surface of a metallic container
07/24/14Preparation comprising insulin, nicotinamide and an amino acid

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Novo Nordisk A s in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Novo Nordisk A s with additional patents listed. Browse our Agent directory for other possible listings. Page by